FR2776521B1 - Utilisation de conjugues p40 actifs par voie nasale - Google Patents

Utilisation de conjugues p40 actifs par voie nasale

Info

Publication number
FR2776521B1
FR2776521B1 FR9803814A FR9803814A FR2776521B1 FR 2776521 B1 FR2776521 B1 FR 2776521B1 FR 9803814 A FR9803814 A FR 9803814A FR 9803814 A FR9803814 A FR 9803814A FR 2776521 B1 FR2776521 B1 FR 2776521B1
Authority
FR
France
Prior art keywords
nasal
active conjugates
conjugates
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9803814A
Other languages
English (en)
Other versions
FR2776521A1 (fr
Inventor
Christine Andreoni
Isabelle Rauly
Thien Ngoc Nguyen
Jean Francois Haeuw
Thierry Baussant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9803814A priority Critical patent/FR2776521B1/fr
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Priority to CNB998062650A priority patent/CN1243569C/zh
Priority to CA002324477A priority patent/CA2324477A1/fr
Priority to JP2000540854A priority patent/JP2002509897A/ja
Priority to PCT/FR1999/000703 priority patent/WO1999049892A2/fr
Priority to BR9909180-1A priority patent/BR9909180A/pt
Priority to AU29391/99A priority patent/AU764061B2/en
Priority to EP99910434A priority patent/EP1066054A2/fr
Publication of FR2776521A1 publication Critical patent/FR2776521A1/fr
Application granted granted Critical
Publication of FR2776521B1 publication Critical patent/FR2776521B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9803814A 1998-03-27 1998-03-27 Utilisation de conjugues p40 actifs par voie nasale Expired - Fee Related FR2776521B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9803814A FR2776521B1 (fr) 1998-03-27 1998-03-27 Utilisation de conjugues p40 actifs par voie nasale
CA002324477A CA2324477A1 (fr) 1998-03-27 1999-03-26 Utilisation de conjugues p40 actifs par voie nasale
JP2000540854A JP2002509897A (ja) 1998-03-27 1999-03-26 経鼻送達のための活性ｐ４０コンジュゲートの使用
PCT/FR1999/000703 WO1999049892A2 (fr) 1998-03-27 1999-03-26 Utilisation de conjugues p40 actifs par voie nasale
CNB998062650A CN1243569C (zh) 1998-03-27 1999-03-26 活性p40结合物在鼻腔途径给药中的应用
BR9909180-1A BR9909180A (pt) 1998-03-27 1999-03-26 Utilização de pelo menos um fragmento de uma proteìna de membrana e processo de prepração de uma proteìna ou um de seus fragmentos por via recombinante
AU29391/99A AU764061B2 (en) 1998-03-27 1999-03-26 Use of active P40 conjugates for nasal delivery
EP99910434A EP1066054A2 (fr) 1998-03-27 1999-03-26 Utilisation de conjugues p40 actifs par voie nasale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9803814A FR2776521B1 (fr) 1998-03-27 1998-03-27 Utilisation de conjugues p40 actifs par voie nasale

Publications (2)

Publication Number Publication Date
FR2776521A1 FR2776521A1 (fr) 1999-10-01
FR2776521B1 true FR2776521B1 (fr) 2000-12-15

Family

ID=9524572

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9803814A Expired - Fee Related FR2776521B1 (fr) 1998-03-27 1998-03-27 Utilisation de conjugues p40 actifs par voie nasale

Country Status (8)

Country Link
EP (1) EP1066054A2 (fr)
JP (1) JP2002509897A (fr)
CN (1) CN1243569C (fr)
AU (1) AU764061B2 (fr)
BR (1) BR9909180A (fr)
CA (1) CA2324477A1 (fr)
FR (1) FR2776521B1 (fr)
WO (1) WO1999049892A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798857B1 (fr) * 1999-09-23 2003-06-06 Pf Medicament Utilisation d'une proteine de membrane ompa d'enterobacterie associee a un peptide immunogene du vrs pour la preparation de vaccins administrables par voie nasale
FR2805163A1 (fr) * 2000-02-21 2001-08-24 Pf Medicament Utilisation d'un detergent de type zwittergent pour la preparation d'une composition pharmaceutique destinee a etre administree par voie nasale
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
AU2001286405B2 (en) * 2000-07-31 2007-05-10 Yale University Innate immune system-directed vaccines
FR2827605B1 (fr) 2001-07-20 2004-07-16 Pf Medicament Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
FR2828106A1 (fr) * 2001-08-02 2003-02-07 Pf Medicament Utilisation d'une omp d'enterobacterie de faible masse moleculaire comme porteur et/ou adjuvant
CN112062820B (zh) * 2020-08-24 2023-05-26 黑龙江八一农垦大学 大肠杆菌重组外膜蛋白a包涵体蛋白的复性纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
FR2718452B1 (fr) * 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
FR2726472B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
FR2748476B1 (fr) * 1996-05-07 1998-08-14 Pf Medicament Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant

Also Published As

Publication number Publication date
BR9909180A (pt) 2000-12-05
CN1243569C (zh) 2006-03-01
AU764061B2 (en) 2003-08-07
CA2324477A1 (fr) 1999-10-07
EP1066054A2 (fr) 2001-01-10
WO1999049892A3 (fr) 2000-03-30
AU2939199A (en) 1999-10-18
JP2002509897A (ja) 2002-04-02
FR2776521A1 (fr) 1999-10-01
CN1301176A (zh) 2001-06-27
WO1999049892A2 (fr) 1999-10-07

Similar Documents

Publication Publication Date Title
EE200000438A (et) Farmatseutiliselt aktiivne morfolinool
PT1220856E (pt) Compostos farmaceuticamente activos
DE60045264D1 (de) Fixationssystem
DE69908568D1 (de) Herbizid aktive 3-hydroxy-4-aryl-5-oxopyrazolinderivate
DE50004430D1 (de) Fahrzeugelektrik-konfigurationssystem
PT1163237E (pt) Derivados de amida
ID22878A (id) Komposisi aktif secara terapi
ATE309998T1 (de) Pharmazeutisch wirksamer sulfonamid derivaten
DE60031633D1 (de) Wirkstofffreisetzendes elastisches band
DK1237408T3 (da) Hæld-på-formuleringer
FR2771012B1 (fr) Pulverisateur nasal
DE60029404D1 (de) Wirkstoffabgabesysteme
DE60012086D1 (de) Gallenshunt
DE29717429U1 (de) Bandagen-System
ES1044448Y (es) Auto-aplicador de vendaje
DE69841863D1 (de) Ostomievorrichtungen
FR2776521B1 (fr) Utilisation de conjugues p40 actifs par voie nasale
ID24677A (id) Kombinasi senyawa aktif fungisidal
DE59902159D1 (de) Aktiver mikromischer
DE60003897D1 (de) Sprühvorrichtung
UA3744S (uk) Розпилювач
NO992607L (no) System med sårhelende virkning
DE59903807D1 (de) Wirkstoffkonzentrat
DE29718838U1 (de) Nasenflügelspreizer
UA4804S (uk) Розподільник інсектициду

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20061130